The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant

Valutazione media 3,33
( su 21 valutazioni fornite da Goodreads )
 
9780471679066: The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant

An in-depth look at big pharma's flagship company
The Merck Druggernaut takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec. Consistently named one of Fortune magazine's Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author Fran Hawthorne, one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much-needed insight on the cutthroat world of pharmaceuticals. It's a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business's most recognizable names, The Merck Druggernaut takes a thoughtful look at some of the major issues of our time and the way those issues intertwine with the world of business.

Fran Hawthorne (New York, NY) is the Assistant Managing Editor at Crain's New York Business. She has been covering business for more than twenty years for such publications as Fortune, BusinessWeek, and Institutional Investor, with a prevailing interest in healthcare and pharmaceuticals. At Crain's, she spearheads the publication of two to three special healthcare issues per year.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

From the Inside Flap:

"We try never to forget that medicine is for the people. It is not for the profits. The profits follow, and if we have remembered that, they have never failed to appear. The better we have remembered that, the larger they have been."
–George W. Merck

In the highly competitive world of pharmaceuticals, George W. Merck’s motto may seem like an unrealistic vision, but it is this exact image that has separated Merck from the rest of Big Pharma–for better or for worse. Whether speaking in terms of product or philanthropy, numbers or niceties, Merck, for decades, set the benchmark for its industry. But what happens when profitable drug patents expire, research on new drugs runs into problems, and an industry’s image comes under attack?

The Merck Druggernaut offers the intriguing inside story of this incredibly secretive pharmaceutical giant–from where it has been and where it is, to where it might be going. Through interviews with individuals who work and have worked at Merck, as well as those outside the company, healthcare and business journalist Fran Hawthorne weaves an engaging tale of two Mercks.

On the one hand, you’ll watch as a company, beloved by investors and headed by such legendary leaders as George W. Merck and P. Roy Vagelos, discovers a treatment for river blindness in Africa and hands out the drug for free. You’ll also learn how Merck developed groundbreaking medications for diseases that previously had no effective products–Mevacor and Zocor® for cholesterol as well as Crixivan® for AIDS. On the other hand, you’ll witness a company whose struggle to produce great new drugs coincides with a sharp decline in its stock price as well as profits. You’ll also get an up-close and personal look at how doctors, insurance companies, generic drug makers, and politicians are confronting Merck, as well as the rest of the pharmaceutical industry.

More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business’s most recognizable names, The Merck Druggernaut takes a thoughtful look at some of today’s major healthcare issues and the way those issues intertwine with the world of business. The Merck Druggernaut paints a compelling picture of a company that has everyone asking: Can Merck ever be Merck again?

From the Back Cover:

PRAISE FOR The Merck Druggernaut

"Few business stories involve life and death. This one does, and Fran Hawthorne tells it with insight and verve. This is an important book for anyone who has ever taken a pill or prescribed one (or bought a pharmaceutical share). It ought to be read as carefully as the directions on a prescription bottle."
—Firth Calhoun, Editor at Large, Institutional Investor

"Fran Hawthorne has produced a compelling, detail-rich account of how the once-mighty Merck has fallen from its perch atop the drug industry amid the turmoil that has shaken all the players in the business. Anyone seeking to understand the vast changes this critical industry has undergone in recent years should read The Merck Druggernaut."
—Hilary Rosenberg, author of The Vulture Investors and A Traitor to His Class

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

I migliori risultati di ricerca su AbeBooks

1.

Hawthorne, Fran
Editore: Wiley
ISBN 10: 0471679062 ISBN 13: 9780471679066
Nuovi PAPERBACK Quantità: 1
Da
Paisleyhaze Books
(New Hartford, CT, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Wiley. PAPERBACK. Condizione libro: New. 0471679062 Wiley trade paperback, unused, No remainder marks or other defects, (New); We will bubble-wrap the book and ship it in a BOX with free delivery confirmation/tracking. Codice libro della libreria 70492

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 8,36
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 4,30
In U.S.A.
Destinazione, tempi e costi

2.

Fran Hawthorne
Editore: John Wiley and Sons Ltd, United States (2005)
ISBN 10: 0471679062 ISBN 13: 9780471679066
Nuovi Paperback Quantità: 1
Da
The Book Depository US
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro John Wiley and Sons Ltd, United States, 2005. Paperback. Condizione libro: New. Language: English . Brand New Book. An in-depth look at big pharma s flagship company The Merck Druggernaut takes readers inside Merck, the world s second most profitable drug company and maker of the world s bestselling drug, Prilosec. Consistently named one of Fortune magazine s Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author Fran Hawthorne, one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much-needed insight on the cutthroat world of pharmaceuticals. It s a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business s most recognizable names, The Merck Druggernaut takes a thoughtful look at some of the major issues of our time and the way those issues intertwine with the world of business. Fran Hawthorne (New York, NY) is the Assistant Managing Editor at Crain s New York Business. She has been covering business for more than twenty years for such publications as Fortune, BusinessWeek, and Institutional Investor, with a prevailing interest in healthcare and pharmaceuticals. At Crain s, she spearheads the publication of two to three special healthcare issues per year. Codice libro della libreria AAH9780471679066

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 12,78
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

3.

Fran Hawthorne
Editore: John Wiley and Sons Ltd, United States (2005)
ISBN 10: 0471679062 ISBN 13: 9780471679066
Nuovi Paperback Quantità: 1
Da
The Book Depository
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro John Wiley and Sons Ltd, United States, 2005. Paperback. Condizione libro: New. Language: English . Brand New Book. An in-depth look at big pharma s flagship company The Merck Druggernaut takes readers inside Merck, the world s second most profitable drug company and maker of the world s bestselling drug, Prilosec. Consistently named one of Fortune magazine s Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author Fran Hawthorne, one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much-needed insight on the cutthroat world of pharmaceuticals. It s a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business s most recognizable names, The Merck Druggernaut takes a thoughtful look at some of the major issues of our time and the way those issues intertwine with the world of business. Fran Hawthorne (New York, NY) is the Assistant Managing Editor at Crain s New York Business. She has been covering business for more than twenty years for such publications as Fortune, BusinessWeek, and Institutional Investor, with a prevailing interest in healthcare and pharmaceuticals. At Crain s, she spearheads the publication of two to three special healthcare issues per year. Codice libro della libreria AAH9780471679066

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 13,27
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

4.

Fran Hawthorne
Editore: John Wiley and#38; Sons (2005)
ISBN 10: 0471679062 ISBN 13: 9780471679066
Nuovi Quantità: > 20
Print on Demand
Da
Pbshop
(Wood Dale, IL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro John Wiley and#38; Sons, 2005. PAP. Condizione libro: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Codice libro della libreria IQ-9780471679066

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 11,53
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,43
In U.S.A.
Destinazione, tempi e costi

5.

Fran Hawthorne
Editore: Wiley (2005)
ISBN 10: 0471679062 ISBN 13: 9780471679066
Nuovi Paperback Quantità: 1
Da
Irish Booksellers
(Rumford, ME, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Wiley, 2005. Paperback. Condizione libro: New. book. Codice libro della libreria 0471679062

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 17,24
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

6.

Fran Hawthorne
Editore: John Wiley and Sons Ltd
ISBN 10: 0471679062 ISBN 13: 9780471679066
Nuovi Paperback Quantità: 1
Da
THE SAINT BOOKSTORE
(Southport, Regno Unito)
Valutazione libreria
[?]

Descrizione libro John Wiley and Sons Ltd. Paperback. Condizione libro: new. BRAND NEW, The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant, Fran Hawthorne, An in-depth look at big pharma's flagship company The Merck Druggernaut takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec. Consistently named one of Fortune magazine's Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author Fran Hawthorne, one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much-needed insight on the cutthroat world of pharmaceuticals. It's a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business's most recognizable names, The Merck Druggernaut takes a thoughtful look at some of the major issues of our time and the way those issues intertwine with the world of business. Fran Hawthorne (New York, NY) is the Assistant Managing Editor at Crain's New York Business. She has been covering business for more than twenty years for such publications as Fortune, BusinessWeek, and Institutional Investor, with a prevailing interest in healthcare and pharmaceuticals. At Crain's, she spearheads the publication of two to three special healthcare issues per year. Codice libro della libreria B9780471679066

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 10,11
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 7,75
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

7.

Hawthorne, Fran
Editore: Wiley (2017)
ISBN 10: 0471679062 ISBN 13: 9780471679066
Nuovi Paperback Quantità: 8
Print on Demand
Da
Murray Media
(North Miami Beach, FL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Wiley, 2017. Paperback. Condizione libro: New. This item is printed on demand. Codice libro della libreria 0471679062

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 15,67
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 2,57
In U.S.A.
Destinazione, tempi e costi

8.

Fran Hawthorne
Editore: John Wiley and#38; Sons (2005)
ISBN 10: 0471679062 ISBN 13: 9780471679066
Nuovi Quantità: 1
Da
Books2Anywhere
(Fairford, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro John Wiley and#38; Sons, 2005. PAP. Condizione libro: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Codice libro della libreria FW-9780471679066

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 10,26
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 10,03
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

9.

Hawthorne, Fran
Editore: John Wiley & Sons (2016)
ISBN 10: 0471679062 ISBN 13: 9780471679066
Nuovi Paperback Quantità: 1
Print on Demand
Da
Ria Christie Collections
(Uxbridge, Regno Unito)
Valutazione libreria
[?]

Descrizione libro John Wiley & Sons, 2016. Paperback. Condizione libro: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Codice libro della libreria ria9780471679066_lsuk

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 17,39
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 4,31
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

10.

Fran Hawthorne
Editore: Wiley
ISBN 10: 0471679062 ISBN 13: 9780471679066
Nuovi Paperback Quantità: 20
Da
BuySomeBooks
(Las Vegas, NV, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Wiley. Paperback. Condizione libro: New. Paperback. 290 pages. Dimensions: 8.5in. x 5.7in. x 1.0in.An in-depth look at big pharmas flagship company The Merck Druggernaut takes readers inside Merck, the worlds second most profitable drug company and maker of the worlds bestselling drug, Prilosec. Consistently named one of Fortune magazines Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author Fran Hawthorne, one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much-needed insight on the cutthroat world of pharmaceuticals. Its a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big businesss most recognizable names, The Merck Druggernaut takes a thoughtful look at some of the major issues of our time and the way those issues intertwine with the world of business. Fran Hawthorne (New York, NY) is the Assistant Managing Editor at Crains New York Business. She has been covering business for more than twenty years for such publications as Fortune, BusinessWeek, and Institutional Investor, with a prevailing interest in healthcare and pharmaceuticals. At Crains, she spearheads the publication of two to three special healthcare issues per year. This item ships from multiple locations. Your book may arrive from Roseburg,OR, La Vergne,TN. Paperback. Codice libro della libreria 9780471679066

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 18,86
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,40
In U.S.A.
Destinazione, tempi e costi

Vedi altre copie di questo libro

Vedi tutti i risultati per questo libro